Kuchiza kwa HIV ndi Isentress (raltegravir)

Isentress (ratelgravir) ndi mankhwala oteteza antiretroviral integrase inhibitor omwe amagwiritsidwa ntchito pochiza HIV . Isentress inali yoyamba integrase inhibitor kuti idalandike ndi US Food and Drug Administration (FDA).

Mu October 2007, adapatsidwa chilolezo kwa anthu akuluakulu omwe ankatsutsa mankhwala ena opatsirana pogonana . Koma pofika mwezi wa Julayi 2009, ndipo kenako mu December 2011, a FDA adaonjezera chiwonetsero chake, kuti agwiritsidwe ntchito kwa onse akuluakulu omwe ali ndi HIV, komanso ana a zaka zapakati pa 2-18.

Isentress ndi imodzi mwa mankhwala omwe tsopano akulimbikitsidwa ngati zosankha zoyenera kutsogolo kwa HIV mankhwala ku US

Mapangidwe

Isentress ikupezeka muzinthu zinayi zosiyana:

Musalowe m'malo mwa Isentress chewables kapena kuimitsa mawu kwa mapiritsi a Isentress omwe amawotcha mafilimu monga momwe malembawo salilioequivalent. Gwiritsani ntchito monga momwe adayankhulira (onani Zomwe zili pansipa).

Mlingo

Isentress 400mg, mapiritsi ophimbidwa ndi mafilimu ayenera kuuzidwa kwa akuluakulu komanso ana okalamba omwe angathe kumeza mapiritsi motere:

Mapiritsi otchedwa Isentress amatha kutchulidwa kwa ana omwe amalemera makilogalamu 20 kapena kuposa omwe sangathe kumeza mapiritsi motere:

Mankhwala a Isentress kapena mapiritsi oyenera ayenera kuuzidwa kwa ana omwe amalemera makilogalamu 3kg kupitirira mapaundi 25kg, motere:

Ulamuliro wa Mankhwala

Isentress ingatengedwe kapena popanda chakudya. Isentress sizingathetsedwe zokha ndipo iyenera kulamulidwa ngati gawo limodzi la mankhwala ochepetsa antiretroviral (MAP) .

Zotsatira Zogwirizana

Zotsatira zowonongeka kwambiri (zomwe zimachitika pa 2% kapena zochepa) zimakhala:

Contraindications

Palibe

Kuyanjana kwa Mankhwala Osokoneza Bongo

Chonde dalitsani dokotala ngati mutenga mankhwala aliwonsewa ngati sakuvomerezedwa kuti agwirizanitse ndi Isentress ndipo akhoza kusokoneza chidziwitso cha mankhwala:

Mfundo

Odwala omwe amatha kusokonezeka atayamba Isentress ayenera kuonana ndi adokotala nthawi yomweyo. Chithandizo chiyenera kuimidwa ndipo chithandizo chamankhwala chikafunidwa ngati kuthamanga kumatsagana ndi malungo, minofu kapena ululu wothandizira, zilonda zamtundu kapena zilonda, kufiira kapena kutupa kwa maso, kutupa kwa nkhope kapena pakamwa, kapena mavuto opuma. Odwala omwe kale anali ndi maganizo opatsirana ndi Isentress sayenera kuyambanso kutsutsidwa ndi mankhwala pambuyo pa kuthetsa zizindikiro.

Maphunziro a zinyama sanasonyeze kuti ali ndi ubongo kapena feteleza pamene ali ndi pakati pa mbewa kapena akalulu omwe amapezeka ku Isentress. Komabe, zotsatira za Isentress pa ana omwe ali ndi makanda sizinakhazikitsidwe, ndipo, chifukwa chake, kuyamwitsa sikuvomerezedwa kwa amayi omwe amatenga Isentress.

Zotsatira:

Dipatimenti ya Zaumoyo ndi Zaumunthu (DHHS). "Malangizo othandizira kugwiritsira ntchito ma antiretroviral mu HIV-1-Akuluakulu Okhudzidwa ndi Achinyamata." Rockville, Maryland.

FDA. "FDA ikukulitsa Kugwiritsa ntchito mankhwala osokoneza bongo a HIV kwa ana ndi achinyamata." Silver Spring, Maryland; December 21, 2011.

Reuters. "UPDATE 2-FDA OKs Kugwiritsa Ntchito Merck's Isentress kachilombo ka HIV." July 9, 2009.

US Food and Drug Administration (FDA). "Kuvomerezeka kwa Mankhwala Osokoneza Bongo - Dzina la Mankhwala: Isentress (ratelgravir) Mapiritsi 400mg." Silver Spring, Maryland; October 12, 2007.